BIOMAT Database Logo BIOMAT Database Logo

Fenchone Derivatives as a Novel Class of CB2 Selective Ligands: Design, Synthesis, X-ray Structure and Therapeutic Potential. 2022

Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.

A series of novel cannabinoid-type derivatives were synthesized by the coupling of (1S,4R)-(+) and (1R,4S)-(-)-fenchones with various resorcinols/phenols. The fenchone-resorcinol derivatives were fluorinated using Selectfluor and demethylated using sodium ethanethiolate in dimethylformamide (DMF). The absolute configurations of four compounds were determined by X-ray single crystal diffraction. The fenchone-resorcinol analogs possessed high affinity and selectivity for the CB2 cannabinoid receptor. One of the analogues synthesized, 2-(2',6'-dimethoxy-4'-(2″-methyloctan-2″-yl)phenyl)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol (1d), had a high affinity (Ki = 3.51 nM) and selectivity for the human CB2 receptor (hCB2). In the [35S]GTPγS binding assay, our lead compound was found to be a highly potent and efficacious hCB2 receptor agonist (EC50 = 2.59 nM, E(max) = 89.6%). Two of the fenchone derivatives were found to possess anti-inflammatory and analgesic properties. Molecular-modeling studies elucidated the binding interactions of 1d within the CB2 binding site.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009636 Norbornanes Compounds that include or are derivatives of norbornane(bicyclo[2.2.1]heptane). Norbornane Derivatives,Norbornene Derivatives,Norbornenes,Norcamphanes,Derivatives, Norbornane,Derivatives, Norbornene
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001892 Camphanes Crystalline saturated MONOTERPENES, precursors of borneols and CAMPHENE. Bornanes,Bornenes,Fenchanes
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands.
March 2009, Bioorganic & medicinal chemistry letters,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.
March 2015, European journal of medicinal chemistry,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Novel benzimidazole derivatives as selective CB2 agonists.
July 2008, Bioorganic & medicinal chemistry letters,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands.
September 2013, Chemical biology & drug design,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
March 2004, Bioorganic & medicinal chemistry letters,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
May 2010, Bioorganic & medicinal chemistry,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
May 2007, Journal of medicinal chemistry,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
March 2005, Bioorganic & medicinal chemistry letters,
Reem Smoum, and Christeene Haj, and Shira Hirsch, and Alina Nemirovski, and Zhannah Yekhtin, and Benny Bogoslavsky, and Gaganjyot Kaur Bakshi, and Mukesh Chourasia, and Ruth Gallily, and Joseph Tam, and Raphael Mechoulam
Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists.
March 2023, Archiv der Pharmazie,
Copied contents to your clipboard!